Clinical Trial Record

Return to Clinical Trials

Evaluation of the Impact of Pancreatectomy on Systemic Immunity


2021-02-24


2022-07-27


2022-07-27


40

Study Overview

Evaluation of the Impact of Pancreatectomy on Systemic Immunity

The study aims at establishing the profile of the immune reaction that occurs in the early surgical suites after pancreatectomy. Blood samples will be collected before surgery, (Day-1), at day0, and after surgery at Day 1, Day 3, Day 7 at 1 year after pancreatectomy. Mass cytometry, genomic and transcriptomic approaches will be used to evaluate the immune systemic modulation after surgery.

N/A

  • Pancreas Cancer
  • Pancreatectomy; Hyperglycemia
  • OTHER: Blood sampling
  • IMMUNOPANC-IPC 2018-051

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2019-06-03  

N/A  

2022-01-05  

2019-06-05  

N/A  

2022-01-06  

2019-06-07  

N/A  

2021-05  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Basic Science


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Indication for pancreatectomy

Blood sampling at different time points before and after pancreatectomy

OTHER: Blood sampling

  • 20 mL will be collected at each time point (day-1,day 0, day 1, day 3, day 7, 1 year after pancreatectomy)
Primary Outcome MeasuresMeasure DescriptionTime Frame
Measurement of immune effectors (Tcells, NK) levels after pancreatectomyEvaluation of immune effectors my mass cytometry after pancreatectomy (compared to baseline)1 year
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patient with an indication of pancreatectomy
  • Signed consent form

  • Exclusion Criteria:

  • Neoadjuvant treatment
  • Pregnancy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Olivier Turrini, MD ¨PhD, Institut Paoli-Calmettes

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available